Table 3 Severity of TEAEs during index LOT.

From: LocoMMotion: a study of real-life current standards of care in triple-class exposed patients with relapsed/refractory multiple myeloma – 2-year follow-up (final analysis)

TEAE, n (%)

N = 248

Any TEAE

215 (86.7)

Any serious TEAE

91 (36.7)

Maximum severity of TEAE

Grade 1

17 (6.9)

Grade 2

46 (18.5)

Grade 3

84 (33.9)

Grade 4

46 (18.5)

Grade 5

22 (8.9)

TEAE with outcome death

21 (8.5)a

  1. LOT line of therapy, PD progressive disease, TEAE treatment-emergent adverse event.
  2. a1 patient with unresolved grade 5 TEAE died from PD.
Back to article page